PAA
Peregrine Asset Advisers’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,072
| Closed | -$831K | – | 137 |
|
|
2021
Q4 | $831K | Sell |
11,072
-55
| -0.5% | -$4.13K | 0.34% | 61 |
|
|
2021
Q3 | $1.29M | Buy |
11,127
+1,568
| +16% | +$182K | 0.66% | 44 |
|
|
2021
Q2 | $2.12M | Buy |
+9,559
| New | +$2.12M | 0.97% | 40 |
|
|
2021
Q1 | – | Sell |
-1,162
| Closed | -$201K | – | 140 |
|
|
2020
Q4 | $201K | Buy |
+1,162
| New | +$201K | 0.09% | 126 |
|